256 results
Page 11 of 13
F-1/A
3h40g5bq
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
6-K
EX-99.1
gw15lvdgtz4s o2d153
3 Mar 20
Therapix Biosciences Ltd. Receives Nasdaq Notification Regarding Minimum Bid Requirements
9:00am
6-K
EX-99.1
98rz1or6mw5k4m
7 Feb 20
Report of Foreign Private Issuer
7:38am
F-1
hxfezl p0hfbfvml
31 Jan 20
Registration statement (foreign)
12:00am
6-K
EX-99.1
cc3ot29k 444w69v
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm
424B5
c6e1y2
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
n3ky4ggo66pi0270z ju
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
EX-99.1
tydn3y0ix7 p4x8rw3
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
EX-10.1
nlkfr
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
EX-99.1
pl867
3 Dec 19
Current report (foreign)
12:00am
6-K
EX-99.1
6b7orjy7woq
26 Nov 19
Report of Foreign Private Issuer
4:01pm
6-K
EX-99.1
a2ekrwqqko kr0y
13 Nov 19
Therapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea Program
4:07pm
6-K
EX-99.3
lccui9m r4y
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm
6-K
EX-99.1
6bxbt you19q4m
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm
6-K
EX-99.1
65geuw
15 Oct 19
Therapix Biosciences Announces Positive Data From Recent Pre-Clinical Study for New Drug Candidate THX-210
4:10pm
6-K
EX-99.1
2u09rl6
11 Oct 19
Current Report of Foreign Issuer
12:00am
F-3/A
si60 44xglmkvf
29 Aug 19
Shelf registration (foreign) (amended)
4:49pm
6-K
EX-99.1
q8vzavg kny6zk9n8fvu
27 Aug 19
Current report (foreign)
4:13pm
F-3
lt1ir8k
22 Aug 19
Shelf registration (foreign)
5:25pm
6-K
EX-99.1
z70f j6nt8b
31 Jul 19
Therapix Biosciences Announces Canadian Product LicenseĀ Issuance for TheraPEA (CannAmideā¢), a Non-Opiate Based Pain Management Supplement
4:03pm